Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 11—November 2025
Research
Two Independent Acquisitions of Multidrug Resistance Gene lsaC in Streptococcus pneumoniae Serotype 20 Multilocus Sequence Type 1257
, Wuling Lin, Zhongya Li, Theresa Tran, Benjamin J. Metcalf, Bridget J. Anderson, Keipp H. Talbot, Lesley McGee, and Sopio Chochua
Suggested citation for this article
Abstract
Among >25,000 invasive pneumococcal disease isolates recovered in US locations during 2015–early 2024 through population-based surveillance, we detected 17 case isolates carrying the lsaC gene, which has been shown to confer resistance to clindamycin in group B Streptococcus. Sixteen isolates carried the mef, msrD, tetM, and lsaC genes on a 29-kb mobile element acquired through an interspecies recombination event and were intermediately clindamycin resistant. One isolate acquired a 62-kb mobile element containing the ermB, tetM, and lsaC genes through a transposition event. All 17 cases were in adults, including 4 adults experiencing homelessness and 9 with substance abuse problems. All 17 lsaC-positive isolates shared a 5.2-kb lsaC-containing element precisely integrated within the conserved oriT site of their respective mobile element. Those 17 lsaC-positive strains were all serotype 20, multilocus sequence type 1257, and were recovered recently (2021–2024); isolates 1–16 represented emergent disease clusters in New York and Connecticut.
Streptococcus pneumoniae is a leading pathogen globally and is the most common cause of community-acquired pneumonia, bacterial meningitis, bacteremia, and otitis media. Macrolides are often used to treat pneumococcal respiratory infections, and their frequent use has led to increases of macrolide resistance and coselected lincosamide resistance in S. pneumoniae disease isolates (1). Although β-lactam antibiotics are first-line treatments, established guidelines exist for using intravenous clindamycin to treat community-acquired bacterial pneumonia (CABP) (2).
The 2 major macrolide-resistance mechanisms in streptococci are 23S rRNA methylation by erm gene–encoded methylases (confers resistance to macrolides, lincosamides, and streptogramin B antibiotics) and removal of macrolides by the mef/msrD-encoded efflux pumps. In group B Streptococcus (GBS), 2 additional mechanisms conferring lincosamide resistance have been described: lincosamide modification by nucleotidyltransferases (lnu genes) (3,4), and the resistance to lincosamides, streptogramin A, and pleuromutilins conferred by the lsaE- or lsaC-encoded ATP-binding cassette (ABC) transporters (5,6). Streptogramin antibiotics have been used for skin infections caused by gram-positive species, and although pleuromutilins are primarily used for veterinary purposes (7), use of the pleuromutilin lefamulin has been approved by the US Food and Drug Administration for systemic treatment of CABP in adults (8). In a recent study (9), 211 strains of S. pneumoniae tested, including 105 that were penicillin resistant, were all lefamulin susceptible according to Clinical and Laboratory Standards Institute criteria (10), with MICs <0.25 µg/mL. In this study, we describe the observed acquisitions of a conserved lsaC-containing element in pneumococci that appear to have been introduced through 2 independent mechanisms of horizontal transfer into the same serotype 20, multilocus sequence type (ST) 1257 (serotype 20/ST1257) strain lineage.
Active Bacterial Core Surveillance Data
We defined invasive pneumococcal disease (IPD) cases through isolating S. pneumoniae from a normally sterile site in an Active Bacterial Core surveillance (ABCs) (11) area resident. The surveillance sites included entire US states or selected counties in 10 states, representing ≈30–35 million persons during 2015–2024 (11). We reviewed case medical charts to obtain demographic information. We defined adults experiencing homelessness as adults documented as homeless or residing in a shelter, mission, medical respite, or church community center at the time of positive culture. This activity was reviewed by a Centers for Disease Control and Prevention (CDC) review board, was deemed not to be human participants research, and was conducted consistent with applicable federal law and CDC policy. ABCs sites obtained ethics approval from their state health department and academic partner institutional review boards as necessary.
ABCs Isolate Characterization
Isolates were assigned serotypes, multilocus STs, and resistance features employing short-read whole-genome sequencing as previously described within the CDC Pneumonia and Streptococcus Laboratory Branch (National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases) (12,13). We deposited genome sequences in the National Center for Biotechnology Information Sequence Read Archive (BioProject no. PRJNA284954). We used broth microdilution testing in the Pneumonia and Streptococcus Laboratory Branch as previously described (14) to verify resistance phenotypes predicted for clindamycin, erythromycin, tetracycline, and tiamulin. Tiamulin has the same mechanism of action as lefamulin, and the 2 antimicrobial drugs share closely similar MICs for pneumococci and for bacterial in vitro transcription-translation (15). Pneumococcal susceptibility to lefamulin corresponds to a MIC of <0.5 µg/mL according to Clinical and Laboratory Standards Institute guidelines (10).
Long-Read Sequencing
Long-read sequencing was conducted by the CDC Biotechnology Core Facility Branch (Office of Laboratory Systems and Response, Division of Core Laboratory Services and Response) to provide a single contig genome resource of a representative lsaC-positive isolate and to map the lsaC element; the PacBio Microbial Multiplexing procedure (Pacific Biosciences, https://www.pacb.com) was implemented. Genomic DNA extracted for short-read sequencing was also used to generate a representative single contig genome (isolate identifier 20234456). We generated libraries using the SMRTbell Express Template Prep Kit 3.0 and size-selected using a 0.45x Ampure bead cleanup (Pacific Biosciences) to remove small DNA (<5 kb). We sequenced final libraries for 30 hours after 30 minutes preextension times on the Sequel II using Sequel II Binding Kit 3.2 (Pacific Biosciences). We used PacBio HiFi reads in Flye v2.9 (16,17) to conduct de novo assembly for the genome size of 2.13 Mb and evaluated the assembled circularized contig by using BLAST + 2.9.0 (18). A coverage of 367 was obtained for the laboratory identification 20234456 genome, which we deposited into GenBank (accession no. CP178339).
Genomic Analyses
We used Prokka version 1.14.5 (19) to obtain annotated open reading frames and then used EasyFig version 2.2.3 (20) to align sequences and generate figures. We generated core-genomic maximum parsimony trees and pairwise single-nucleotide polymorphism (SNP) matrices from short-read bacterial genome sequences using kSNP3.0 with a kmer size of 19 (21). We used resultant core.tre files generated from kSNP3.0 to generate core-genomic pairwise SNP comparisons and phylogenetic diagrams using MEGA7 (22). We used the Proksee website (23) to generate a circular map of a representative lsaC-positive isolate and to predict mobile element genes using the mobileOG-db database (24). We used progressive Mauve (25) to generate aligned core genomes of representative serotype 20/ST1257 isolates and subjected toregenome alignments to Gubbins (26) to identify recombinant regions.
Serotype 20/ST1257 Invasive Pneumococcal Disease Isolate Phylogeny
Genomic sequence–based ABCs strain surveillance carried out during 2015–2023 (3 serotype 20/ST1257 isolates [1 lsaC-positive] were also included from 2024) included >25,000 genomes from invasive pneumococcal disease (IPD) case isolates recovered during this period. Of those, 17 IPD isolates recovered during 2020–early 2024 tested positive for the lsaC determinant (Table). All 17 lsaC-positive isolates were serotype 20/ST1257, were recovered from adults 34–84 years of age, and were among 367 serotype 20/ST1257 IPD isolates recovered during 2015–early 2024.
Figure 1
Figure 1. Core-genomic phylogeny representative serotype 20/ST1257 invasive pneumococcal disease isolates recovered during 2015–2024 in study of independent acquisitions of multidrug resistance gene lsaC in serotype 20/ST1257 Streptococcus pneumoniae...
A single lsaC-positive isolate (isolate 17) recovered in Tennessee was ermB+/tetM+ and was phylogenetically distinct from lsaC-positive isolates 1–16 recovered in New York and Connecticut that were positive for the mef/msrD macrolide efflux genes and tetM (Figure 1). The phylogenetic tree revealed 2 separate geographic clusters corresponding to New York and Connecticut. Twelve genomes (representing all 6 Connecticut isolates and 6 New York isolates) revealed a range of 2–20 pairwise SNP differences; the average was 11 SNPs. The genomes from 4 New York isolates recovered during 2022–2024 formed a separate subcluster (Figure 1); the pairwise SNP difference range was 5–14 SNPs (average of 9.5 SNPs).
Resistance Phenotypes
Isolate 17 was fully resistant to clindamycin (MIC >2 µg/mL) and erythromycin (MIC 4 µg/mL). Isolates 1–16 shared the clindamycin MIC of 0.5 µg/mL and erythromycin MICs of 2–8 µg/mL, compared with MICs of <0.12 µg/ml for clindamycin and erythromycin in control serotype 20/ST1257 isolate 20195631 and strain ATCC49619 (Table).
All 17 lsaC-positive isolates tested as susceptible to lefamulin (MIC range of <0.25–0.5 µg/mL). However, isolates 1–3 revealed MICs to both pleuromutilins that were above control values, and isolates 4–11 revealed MICs to 1 pleuromutilin that were above control values. Although inconclusive, those data are consistent with the lsaC gene conferring reduced susceptibility to pleuromutilins compared with lsaC-negative strains, especially when considering that the lsaC determinant in isolates 1–16 appears to encode an active clindamycin efflux component conferring intermediate clindamycin resistance. Besides isolates 1–17, 5 serotype 20/ST1257 isolates carried resistance determinants, consisting of a single ermB-positive isolate, 2 mef/msrD-positive isolates, and 2 tetM-positive isolates, none of which were phylogenetically related to isolates 1–16 or isolate 17 (Figure 1).
Mobile Element Carrying Isolate 17 lsaC Gene
Figure 2
Figure 2. Complex mobile element within isolate 17 (positive for ermB, tetM, and lsaC) in study of independent acquisitions of multidrug resistance gene lsaCin...
Examination of the region carrying the lsaC gene in isolate 17 revealed a complex 61-kb mobile element of the broad Tn916/Tn1545 conjugative transposon family (27) inserted within the 3′ end of the ribosomal protein gene rplL (corresponding to base 1,215,206 of the Tigr4 reference genome [GenBank accession no. CP000410]). That insertion revealed evidence of a transposition event shown by the tandem repeat of the 3′ 5 codons of the rplL gene at the distal end of the 61-kb element (Figure 2). That element shared its highest similarity to an element from S. intermedius (GenBank accession no. CP003858) with >98% sequence identity over the overlap (Figure 2). The S. intermedius insertion was also within the corresponding site of its rplL gene that shared 90.8% sequence identity with the isolate 17 rplL gene.
Mitis Group Streptococcal Source of Mobile element Carried by Isolates 1–16
Figure 3
![Introduction of isolate 1–16 mobile element into serotype 20/ST1257 by a double crossover homologous transformation event in study of independent acquisitions of multidrug resistance gene lsaC in serotype 20/ST1257 Streptococcus pneumoniae isolates, United States. Crossover 1 occurred within orf5 and crossover 2 occurred near the 5′ end of orf16. Apparent nonpneumococcal homolog genes in isolates 1–16 (serotype 20/ST1257 [mef, msrD, tetM, lsaC]) flanking the mobile element (orf 5–16) are indicated upstream in brown, as is most of orf17 immediately downstream of the insertion element. These genes share <90% sequence identity with the parental strain lineage serotype 20/ST1257. The section corresponding to orf17 has been modified from the original EasyFig (20) depiction to reflect more accurately the decreased homology between the 2 orf17 alleles and the actual breakpoint in homology. The repeated 8-bp target site for the ancestral transposition event is indicated. Predicted mobile element genes and functions are indicated in the below grid corresponding to 15–44.2 kb of the entire isolate 1–16 region. orf5 is indicated by 1 open reading frame in isolates 1–16 but is indicated by 2 short homologous reading frames in the parental strain (top). ST, sequence type.](/eid/images/25-1101-F3-tn.jpg)
Figure 3. Introduction of isolate 1–16 mobile element into serotype 20/ST1257 by a double crossover homologous transformation event in study of independent acquisitions of multidrug resistance gene lsaC in serotype 20/ST1257 ...
Figure 4
Figure 4. Near sequence identity shared between pneumococcal isolates 1–15 and Streptococcus pseudopneumoniae strain 315_SPE in mobile element insertion region in study of independent acquisitions of multidrug resistance gene ...
Figure 5
Figure 5. Single contig genome of isolate 20234456 (msrD-positive, mef-positive, tetM-positive, lsaC-positive) representative of isolates 1–16 in study of independent acquisitions of multidrug resistance...
Figure 6
Figure 6. Alignments between Streptococcus mitis strain, pneumococcal isolates 1–16, S. pseudopneumoniaestrain 315_SPSE, and pansusceptible serotype 20/ST1257 pneumococcal strain (bottom) in study of independent acquisitions of multidrug resistance...
Figure 7
Figure 7. Related regions shared between the 2 pneumococcal lsaC elements from this study, the mobile element found in S. pseudopneumoniae315_SP_SPSE, and the partial mobile element from GBS...
Isolates 1–16 carried an identical 41-kb region that consisted of a 29-kb mobile element flanked by ≈12 kb of upstream and 1 kb of downstream divergent chromosomal sequence that shared 88% sequence identity with the corresponding region of serotype 20/ST1257 pansusceptible isolates (Figure 3). This flanking region and the predicted mobile element shared >99% sequence identity to its closest match in GenBank, S. pseudopneumoniae strain 315_SPSE (accession no. NZ_JVLX00000000) (Figure 4). The upstream crossover in this presumed homologous recombination event occurred just downstream of ribosomal protein gene rpsD (position 89,092 within lsaC-positive serotype 20ST/1257 strain 20234456) (Figure 5); the downstream crossover point corresponded to base 130,195 within putative transport protein gene orf17. Those positions corresponded to base 86,400 (upstream crossover) and 97,643 (downstream crossover) of the Tigr4 reference genome. S. pseudopneumoniae strain 315_SPSE was an outlier, in that the next 10 closest matches to the 12-kb flanking sequences, although representative of S. pseudopneumoniae and S. mitis strains, shared only ≈95% sequence identity to the 12-kb flanking sequence as depicted compared with both S. mitis (strain B146_S64, GenBank accession no. GCA_946184845.1) and S. pneumoniae 315_SPSE (Figure 6). The predicted 29-kb mobile element from isolates 1–16 shared high similarity in its overlap with the mobile element in isolate 16 except for presence of the 5.3 kb mef/msrD region and lack of the 2 kb ermB region (Figure 7, panel A).
5255-bp Integrative lsaC Element Shared by lsaC-Carrying Isolates
All 17 lsaC-positive isolates carried the complete 1,479-bp lsaC gene as part of a 5,255-bp integrative element also conserved with a counterpart locus in the GBS strain UCN70 (5) and predicted to carry genes encoding a site-specific integrase and a replication initiation protein (Figure 7, panel A). The 5,255-bp isolate 1–16 lsaC element differed by 5 bp from isolate 17 and 10 bp from GBS UCN70. The isolate 1–16 lsaC allele differed from the isolate 17 lsaC allele by 2 missense substitutions, and those 2 alleles differed from GBS UCN70 lsaC allele by 1–2 missense substitutions. As described for related lsaC elements (6), each 5,255-bp element contained flanking homologous junctions (j1 and j2 in Figure 7, panel B) that shared repeated regions after a run of 6 Cs (j1) or preceding a run of 5–7 Gs (j2). Junctions j1 and j2 each shared overlapping sequence nearly identical to an oriT sequence motif shared by various related conjugative transposons, indicative of specific integration of the 3 different 5,255-bp lsaC elements within transposons harboring an identical oriT (Figure 7, panel B).
Features of Serotype 20/ST1257 Cases
Only 9 of the 367 serotype 20/ST1257 case-patients were <18 years of age; only 1 patient was <5 years of age. Of the 357 case-patients with known residence status, 50 (14.0%) were adults experiencing homelessness, including 4 (23.5%) of the case-patients whose cases corresponded to isolates 1–17. This finding is consistent with data from ABCs in 2018 and 2019 (28,29), in which serotype 20 made up the third highest proportion of cases among adults experiencing homelessness, surpassed only by serotypes 4 and 12F. Of serotype 20 cases, 14.9% were from adults experiencing homelessness in 2018 and 12.2% were from adults experiencing homelessness in 2019. Typical of serotypes more common among adults experiencing homelessness (29), 9 of the 17 serotype 20 lsaC-positive isolates were recovered from adults with substance use problems involving cocaine or methamphetamines (6 persons, 1 of which was an adult experiencing homelessness) or alcohol (2 persons).
Contribution of Interspecies and Intraspecies Recombination to Apparent Phylogenic Distance of Isolates 1–16 from Closest Pansensitive Ancestor
To assess temporal distances between lsaC-positive genetic progeny and their closest ancestors, we generated a core-genome phylogeny of serotype 20/ST1257 IPD isolates (Figure 1). Isolate 17 differed by only 12 SNPs from the closest pansensitive strains (Figure 1). That finding is consistent with a recent transposition event in which the mobile element was precisely inserted within the genomic rplL gene (Figure 2). In contrast, the inner subbranch separating isolates 1–16 from its predicted most common ancestor showed a distance of ≈130 SNPs. The distance between closest pansensitive isolates (2 isolates recovered in Connecticut during 2015–2018) and the subcluster of 6 New York isolates within isolates 1–16 was 140–180 SNPs. Through recombination analysis of aligned genomes (26), all or most of this pairwise distance (152 SNPs) was introduced into the depicted phylogeny (Rec1 in Figure 1) by the single interspecies recombination event that introduced the resistance element along with ≈13 kb of nonpneumococcal flanking core-genomic sequence (Figures 3–5).
The 10 New York isolates (all recovered during 2022–2024) were additionally subdivided into 2 subclusters by 5 recombinant fragments uniformly present in the distal 4 isolates on the tree (data not shown). The most distal subcluster (consisting of isolates recovered during 2022–2024) displayed considerable distance (104–117 SNPs) from the other 6 New York isolates (recovered during 2022–2023). The 5 recombinant regions within the 4 distal subcluster isolates ranged from 750–9,020 bp in length and accounted for all or most of this entire SNP distance between the 2 subgroups (Rec2 in Figure 1); that finding was indicative of a close temporal distance between those 4 isolates and the 6 ancestral New York isolates.
lsaC determinants have been described from GBS (5,6) and very recently have been reported from animal strains of S. equisimilis (30). In this study, we identified 2 independent introductions of lsaC into pneumococci where the determinant is present on 2 distinct mobile elements, 1 cocarrying ermB and tetM, and 1 cocarrying mef, msrD, and tetM. Within both mobile elements, the lsaC component element targeted oriT through a conserved mechanism first described in GBS (6). Within isolate 17, the large mobile element carrying ermB and tetM was likely to have been first introduced into the genome through transposition targeting the rplL 3′ 15-bp target, followed by oriT-targeted insertion of lsaC. Disruption of the oriT sequence would presumably prevent further high-frequency transposition of the composite transposon containing ermB, tetM, and lsaC. Because the mobile element observed within isolates 1–16 was introduced through interspecies homologous transformation (31) and not by conjugative transposition requiring an intact oriT, predicting whether the lsaC element was cocarried with other resistance genes or introduced subsequently is not possible. These 2 lsaC elements did not recently originate from the same donor bacterial strain; they differed by 5 SNPs, including 2 missense substitutions within the lsaC gene. The apparent oriT-targeting mechanism of lsaC horizontal transfer has the potential to include numerous bacterial species because of the ubiquity of conjugative elements sharing the oriT target for lsaC element insertion and the presence of transposition genes (site specific integrase/replication initiation) genes within the lsaC element itself.
Serotype 20 is one of the few serotypes that have an extremely high propensity for generating genomic clusters among IPD isolates recovered from adults, where a so-called clustering isolate differs from >1 isolates by <10 SNPs (28,29,32,33). The 23-valent pneumococcal polysaccharide vaccine introduced in 1983 contains a serotype 20 component; however, the immunity conferred by this vaccine decreases within a few years (34). Despite the introduction of highly effective pneumococcal protein-polysaccharide conjugate vaccines, starting with the 7-valent vaccine (PCV7) in 2000, serotype 20 was not included within another licensed vaccine until the licensure of PCV21 in 2024 for adults 19–64 years of age with risk conditions for IPD and for those >65 years (35). The serotypes that have the highest proportions of clustering IPD isolates, such as 4, 12F, and 20, have the greatest propensity to cause IPD among adults experiencing homelessness and are rarely found in carriage (35–39). Those serotypes have been characterized as short carriage–duration serotypes (40) and rapidly spread between adults, causing IPD in vulnerable hosts shortly after acquisition in carriage (40,41). Serotypes such as 4, 12F, and 20 differ from serotypes often found in pediatric carriage, such as 35B and 19A (35,36) that are associated with relatively low frequencies of genomic clustering (29). The prevalence in IPD of such long duration–carriage serotypes as 35B and 19A appear directly related to their higher detection incidence in pediatric carriage (35–37,39); that observation is supported by the well-characterized herd effect of adult IPD prevention affected by high coverage of conjugate vaccines among the pediatric population (41,42).
Serotype 4, which has the highest propensity for both genomic clusters and causing IPD among adults experiencing homelessness, was recently found to acquire reduced susceptibility to vancomycin through the acquisition of a vanG-containing mobile element (14). The acquisitions of vanG and lsaC in pneumococci had not been reported before those very recent observations of their presence in the short carriage–duration serotypes. Another recent and unusual finding within those high-clustering serotypes was the generation of a serotype 12F to serotype 4 serotype-switch variant IPD cluster causing multiple IPD cases among adults experiencing homelessness (32). Recent increases (45) in the number of persons lacking permanent shelter (record numbers of 653,104 persons in 2023 and 771,480 persons in 2024) are likely to directly correlate to concurrent increases of IPD caused by high-clustering serotypes among adults experiencing disadvantages (28,29,32,33,45,46). Those increases might have contributed to unusual interspecies and intraspecies horizontal genetic transfer events involving those serotypes.
The acquisition of lsaC in isolate 17 is of potential medical significance, even though the strain is already fully clindamycin resistant through the presence of ermB on the same mobile element. Even though streptogramin A and pleuromutilin antibiotics are currently used primarily for veterinary purposes (7), the pleuromutilin lefamulin was recently approved for systemic use in cases of CABP in adults (8). Although all 17 isolates in this study were susceptible to lefamulin, 4 tested at the breakpoint of susceptibility, and 10 revealed MICs that were above control values for the closely related pleuromutilin tiamulin. In view of the cross-resistance to clindamycin and pleuromutilins observed in GBS, it is reasonable to assume lsaC-conferred intermediate clindamycin-resistance and to suspect reduced pleuromutilin susceptibility in isolates 1–16. In isolates 1–16, the presence of lsaC would prevent the use of clindamycin for certain situations, such as strain penicillin resistance or patient allergy in CABP cases. The physical linkage of lsaC with other resistance genes also provides the obvious potential for coselection of the unrelated resistance determinants in bacterial strains.
Of note, isolates 1–16 appear to have recently emerged and are actively expanding within 2 different ABCs sites; the most recent isolate appeared within the small proportion of 2024 ABCs strain surveillance completed at that time. The apparent temporal distance shown between the isolate 1–16 lineage and pansusceptible serotype 20/ST1257 isolate is mainly artifactual because of SNPs introduced through recombination at the lsaC insertion region of the genome. This lsaC-positive cluster has continued to recently diversify; a 4-isolate subcluster revealed multifragment recombination, which appears to commonly occur in pneumococci from a single exposure to donor DNA (32,48).
The recent acquisitions of lsaC and vanG within invasive pneumococci highlight the granular nature of whole-genome sequence–based disease strain surveillance for detecting rare resistance gene acquisition events and for monitoring subsequent spread of such novel strains. With continued narrowing of available antibiotic choices for treating bacterial infections, maintaining this vigilance through long-term surveillance of invasive strains is key.
Dr. Beall was a researcher at the Centers for Disease Control and Prevention during 1993–2021, where he focused on streptococcal strain characterization and invasive strain surveillance. He was the team lead of the Streptococcus Laboratory during 2004–2021 and since retirement continues to work with the laboratory as a scientific consultant.
Acknowledgments
We thank everyone involved in Active Bacterial Core surveillance, a collaboration between the Centers for Disease Control and Prevention, state health departments, and universities (https://www.cdc.gov/abcs/index.html). We are especially grateful to Lyn Sosa and the Connecticut Active Bacterial Core surveillance site for providing lsaC-positive invasive pneumococcal disease isolates from this surveillance area. We thank Ujwal Bagal and Meghan Bentz and the entire Biotechnology Core Facility Branch for providing long-read sequencing.
This work employed multilocus sequence type data from the pneumococcal database at https://pubmlst.org/organisms/streptococcus-pneumoniae.
References
- Schroeder MR, Stephens DS. Macrolide resistance in Streptococcus pneumoniae. Front Cell Infect Microbiol. 2016;6:98. DOIPubMedGoogle Scholar
- Murphy PB, Bistas KG, Patel P, Le JK. Clindamycin. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Feb 28]. https://www.ncbi.nlm.nih.gov/books/NBK519574
- de Azavedo JC, McGavin M, Duncan C, Low DE, McGeer A. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother. 2001;45:3504–8. DOIPubMedGoogle Scholar
- Achard A, Villers C, Pichereau V, Leclercq R. New lnu(C) gene conferring resistance to lincomycin by nucleotidylation in Streptococcus agalactiae UCN36. Antimicrob Agents Chemother. 2005;49:2716–9. DOIPubMedGoogle Scholar
- Malbruny B, Werno AM, Murdoch DR, Leclercq R, Cattoir V. Cross-resistance to lincosamides, streptogramins A, and pleuromutilins due to the lsa(C) gene in Streptococcus agalactiae UCN70. Antimicrob Agents Chemother. 2011;55:1470–4. DOIPubMedGoogle Scholar
- Douarre PE, Sauvage E, Poyart C, Glaser P. Host specificity in the diversity and transfer of lsa resistance genes in group B Streptococcus. J Antimicrob Chemother. 2015;70:3205–13. DOIPubMedGoogle Scholar
- Schwarz S, Shen J, Kadlec K, Wang Y, Brenner Michael G, Feßler AT, et al. Lincosamides, streptogramins, phenicols, and pleuromutilins: mode of action and mechanisms of resistance. Cold Spring Harb Perspect Med. 2016;6:
a027037 . DOIPubMedGoogle Scholar - US Food and Drug Administration. Xenleta: highlights of prescribing information [cited 2019 Sep 16]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211672s000,211673s000lbl.pdf
- Cao Y, Zhu J, Liang B, Guo Y, Ding L, Hu F. Assessment of lefamulin 20 µg disk versus broth microdilution when tested against common respiratory pathogens. Int J Antimicrob Agents. 2024;64:
107366 . DOIPubMedGoogle Scholar - Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 34th ed (M100-S34). Wayne, PA: The Institute; 2024.
- ABCs Bactfacts Interactive Data Dashboard. Active bacterial core surveillance reports for 1997–2021 [cited 2024 Oct 13]. https://www.cdc.gov/abcs/bact-facts/data-dashboard.html
- Metcalf BJ, Gertz RE Jr, Gladstone RA, Walker H, Sherwood LK, Jackson D, et al.; Active Bacterial Core surveillance team. Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA. Clin Microbiol Infect. 2016;22:60.e9–29. DOIPubMedGoogle Scholar
- Metcalf BJ. CDC streptococcal bioinformatics pipelines [cited 2023 Dec 1]. https://github.com/BenJamesMetcalf
- Chochua S, Beall B, Lin W, Tran T, Rivers J, Li Z, et al. The emergent invasive serotype 4 ST10172 strain acquires vanG type vancomycin resistance element: a case of a 66-year-old with bacteremic pneumococcal pneumonia. J Infect Dis. 2025;231:746–50. DOIPubMedGoogle Scholar
- Paukner S, Riedl R. Pleuromutilins: potent drugs for resistant bugs—mode of action and resistance. Cold Spring Harb Perspect Med. 2017;7:
a027110 . DOIPubMedGoogle Scholar - Kolmogorov M, Yuan J, Lin Y, Pevzner PA. Assembly of long, error-prone reads using repeat graphs. Nat Biotechnol. 2019;37:540–6. DOIPubMedGoogle Scholar
- Lin Y, Yuan J, Kolmogorov M, Shen MW, Chaisson M, Pevzner PA. Assembly of long error-prone reads using de Bruijn graphs. Proc Natl Acad Sci U S A. 2016;113:E8396–405. DOIPubMedGoogle Scholar
- Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al. BLAST+: architecture and applications. BMC Bioinformatics. 2009;10:421. DOIPubMedGoogle Scholar
- Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30:2068–9. DOIPubMedGoogle Scholar
- Sullivan MJ, Petty NK, Beatson SA. Easyfig: a genome comparison visualizer. Bioinformatics. 2011;27:1009–10. DOIPubMedGoogle Scholar
- Gardner SN, Slezak T, Hall BG. kSNP3.0: SNP detection and phylogenetic analysis of genomes without genome alignment or reference genome. Bioinformatics. 2015;31:2877–8. DOIPubMedGoogle Scholar
- Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33:1870–4. DOIPubMedGoogle Scholar
- Grant JR, Enns E, Marinier E, Mandal A, Herman EK, Chen C, et al. Proksee: in-depth characterization and visualization of bacterial genomes nucleic acids research. Nucleic Acids Res. 2023;51(W1):
W484–92 . - Brown CL, Mullet J, Hindi F, Stoll JE, Gupta S, Choi M, et al. mobileOG-db: a manually curated database of protein families mediating the life cycle of bacterial mobile genetic elements. Appl Environ Microbiol. 2022;88:
e0099122 . DOIPubMedGoogle Scholar - Darling AE, Mau B, Perna NT. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One. 2010;5:
e11147 . DOIPubMedGoogle Scholar - Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, Bentley SD, et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res. 2015;43:
e15 . DOIPubMedGoogle Scholar - Clewell DB, Flannagan SE, Jaworski DD, Clewell DB. Unconstrained bacterial promiscuity: the Tn916-Tn1545 family of conjugative transposons. Trends Microbiol. 1995;3:229–36. DOIPubMedGoogle Scholar
- Metcalf BJ, Chochua S, Walker H, Tran T, Li Z, Varghese J, et al. Invasive pneumococcal strain distributions and isolate clusters associated with persons experiencing homelessness during 2018. Clin Infect Dis. 2021;72:e948–56. DOIPubMedGoogle Scholar
- Beall B, Chochua S, Li Z, Tran T, Varghese J, McGee L, et al. Invasive pneumococcal disease clusters disproportionally impact persons experiencing homelessness, injecting drug users, and the western United States. J Infect Dis. 2022;226:332–41. DOIPubMedGoogle Scholar
- Glambek M, Skrede S, Sivertsen A, Kittang BR, Kaci A, Jonassen CM, et al.; Norwegian Study Group on Streptococcus dysgalactiae. Antimicrobial resistance patterns in Streptococcus dysgalactiae in a One Health perspective. Front Microbiol. 2024;15:
1423762 . DOIPubMedGoogle Scholar - D’Aeth JC, van der Linden MP, McGee L, de Lencastre H, Turner P, Song J-H, et al.; GPS Consortium. The role of interspecies recombination in the evolution of antibiotic-resistant pneumococci. Elife. 2021;10:
e67113 . DOIPubMedGoogle Scholar - Beall B, Chochua S, Metcalf B, Lin W, Tran T, Li Z, et al. Increased proportions of invasive pneumococcal disease cases among adults experiencing homelessness sets stage for new serotype 4 capsular-switch recombinant. J Infect Dis. 2025;231:871–82. DOIPubMedGoogle Scholar
- Beall B, Walker H, Tran T, Li Z, Varghese J, McGee L, et al. Upsurge of conjugate vaccine serotype 4 invasive pneumococcal disease clusters among adults experiencing homelessness in California, Colorado, and New Mexico. J Infect Dis. 2021;223:1241–9. DOIPubMedGoogle Scholar
- Sankilampi U, Honkanen PO, Bloigu A, Leinonen M. Persistence of antibodies to pneumococcal capsular polysaccharide vaccine in the elderly. J Infect Dis. 1997;176:1100–4. DOIPubMedGoogle Scholar
- Kobayashi M, Leidner AJ, Gierke R, Farrar JL, Morgan RL, Campos-Outcalt D, et al. Use of 21-valent pneumococcal conjugate vaccine among U.S. adults: recommendations of the Advisory Committee on Immunization Practices—United States, 2024. MMWR Morb Mortal Wkly Rep. 2024;73:793–8. DOIPubMedGoogle Scholar
- Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, Pelton SI, et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009;124:e1–11. DOIPubMedGoogle Scholar
- Sharma D, Baughman W, Holst A, Thomas S, Jackson D, da Gloria Carvalho M, et al. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Pediatr Infect Dis J. 2013;32:e45–53. DOIPubMedGoogle Scholar
- Desai AP, Sharma D, Crispell EK, Baughman W, Thomas S, Tunali A, et al. Decline in pneumococcal nasopharyngeal carriage of vaccine serotypes after the introduction of the 13-valent pneumococcal conjugate vaccine in children in Atlanta, Georgia. Pediatr Infect Dis J. 2015;34:1168–74. DOIPubMedGoogle Scholar
- Milucky J, Carvalho MG, Rouphael N, Bennett NM, Talbot HK, Harrison LH, et al.; Adult Pneumococcal Carriage Study Group. Streptococcus pneumoniae colonization after introduction of 13-valent pneumococcal conjugate vaccine for US adults 65 years of age and older, 2015-2016. Vaccine. 2019;37:1094–100. DOIPubMedGoogle Scholar
- Kellner JD, McGeer A, Cetron MS, Low DE, Butler JC, Matlow A, et al. The use of Streptococcus pneumoniae nasopharyngeal isolates from healthy children to predict features of invasive disease. Pediatr Infect Dis J. 1998;17:279–86. DOIPubMedGoogle Scholar
- Metcalf BJ, Waldetoft KW, Beall BW, Brown SP. Variation in pneumococcal invasiveness metrics is driven by serotype carriage duration and initial risk of disease. Epidemics. 2023;45:
100731 . DOIPubMedGoogle Scholar - Domínguez-Hüttinger E, Boon NJ, Clarke TB, Tanaka RJ. Mathematical modeling of Streptococcus pneumoniae colonization, invasive infection and treatment. Front Physiol. 2017;8:115. DOIPubMedGoogle Scholar
- Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al.; Active Bacterial Core Surveillance/Emerging Infections Program Network. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201:32–41. DOIPubMedGoogle Scholar
- Ahmed SS, Pondo T, Xing W, McGee L, Farley M, Schaffner W, et al. Early impact of 13-valent pneumococcal conjugate vaccine use on invasive pneumococcal disease among adults with and without underlying medical conditions—United States. Clin Infect Dis. 2020;70:2484–92. DOIPubMedGoogle Scholar
- US Department of Housing and Urban Development. Annual homelessness assessment report [cited 2025 Sep 26]. https://www.huduser.gov/portal/datasets/ahar.html
- Kellner JD, Ricketson LJ, Demczuk WHB, Martin I, Tyrrell GJ, Vanderkooi OG, et al. Whole-genome analysis of Streptococcus pneumoniae serotype 4 causing outbreak of invasive pneumococcal disease, Alberta, Canada. Emerg Infect Dis. 2021;27:1867–75. DOIPubMedGoogle Scholar
- Navajo Epidemiology Center. Serotype 4 invasive pneumococcal disease (IPD) information for providers [cited 2024 Jul 22]. https://nec.navajo-nsn.gov/Projects-Reports/Infectious-Disease
- Golubchik T, Brueggemann AB, Street T, Gertz RE Jr, Spencer CC, Ho T, et al. Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event. Nat Genet. 2012;44:352–5. DOIPubMedGoogle Scholar
Figures
Table
Suggested citation for this article: Beall B, Lin W, Li Z, Tran T, Metcalf BJ, Anderson BJ, et al. Two independent acquisitions of multidrug resistance gene lsaC in Streptococcus pneumoniae serotype 20 multilocus sequence type 1257. Emerg Infect Dis. 2025 Nov [date cited]. https://doi.org/10.3201/eid3111.251101
Original Publication Date: November 25, 2025
Table of Contents – Volume 31, Number 11—November 2025
| EID Search Options |
|---|
Advanced Article Search – Search articles by author and/or keyword.
|
Articles by Country Search – Search articles by the topic country.
|
Article Type Search – Search articles by article type and issue.
|
Please use the form below to submit correspondence to the authors or contact them at the following address:
Bearnard Beall, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop C02, Atlanta, GA 30329-4018, USA
Top